MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s11764-023-01483-1

Медицинская библиотека · Journal of cancer survivorship : research and practice · 2023

Trends in physical functioning in acute lymphoblastic leukemia and non-Hodgkin lymphoma survivors across three decades.

Wilson Carmen L, Bjornard Kari L, Partin Robyn E, Kadan-Lottick Nina S, Nathan Paul C, Oeffinger Kevin C, Hayashi Robert J, Hyun Geehong, Armstrong Gregory T, Leisenring Wendy M, Howell Rebecca M, Yasui Yutaka, Dixon Stephanie B, Ehrhardt Matthew J, Robison Leslie L, Ness Kirsten K

СтатьяНаблюдательное исследованиеПоддержка NIH: внешняя программаПоддержка службы здравоохранения СШАПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

PURPOSE: The impact of changes in therapy for childhood acute lymphoblastic leukemia (ALL) and non-Hodgkin lymphoma (NHL) on the prevalence of physical performance limitations and participation restrictions among survivors is unknown. We aimed to describe the prevalence of reduced function among ALL and NHL survivors by treatment era.

METHODS

Participants included survivors of childhood ALL and NHL, and a cohort of their siblings, participating in the Childhood Cancer Survivor Study (CCSS). Physical function was measured using questionnaire. The prevalence of reduced function was compared to siblings using generalized estimating equations, overall and stratified by treatment decade. Associations between organ system-specific chronic conditions (CTCAE v4.03) and function were also evaluated.

RESULTS

Among 6511 survivors (mean age 25.9 years (standard deviation 6.5)) and 4127 siblings, risk of performance limitations (15.2% vs. 12.5%, prevalence ratio [PR] = 1.5, 95%CI = 1.3-1.6), restrictions in personal care (2.0% vs. 0.6%, PR = 3.1, 95% CI = 2.0-4.8), routine activities (5.5% vs. 1.6%, PR = 3.6, 95% CI = 2.7-4.8), and work/school attendance (8.8% vs. 2.1%, PR = 4.5, 95% CI = 3.6-5.7) was increased in survivors vs. siblings. The prevalence of survivors reporting reduced function did not decrease between the 1970s and 1990s. The presence of neurological and cardiovascular conditions was associated with reduced function regardless of treatment decade.

CONCLUSIONS

Despite changes in therapy, the prevalence of poor physical function remained constant between the 1970s and 1990s. The CCSS clinical trial registration number is NCT01120353 (registered May 6, 2010).

IMPLICATIONS FOR CANCER SURVIVORS: Our findings support screening for reduced physical function so that early interventions to improve physical performance and mitigate chronic disease can be initiated.

Для цитирования: Wilson Carmen L, Bjornard Kari L, Partin Robyn E, Kadan-Lottick Nina S, Nathan Paul C, Oeffinger Kevin C, Hayashi Robert J, Hyun Geehong, Armstrong Gregory T, Leisenring Wendy M, Howell Rebecca M, Yasui Yutaka, Dixon Stephanie B, Ehrhardt Matthew J, Robison Leslie L, Ness Kirsten K. Trends in physical functioning in acute lymphoblastic leukemia and non-Hodgkin lymphoma survivors across three decades.. Journal of cancer survivorship : research and practice. 2023. DOI: 10.1007/s11764-023-01483-1.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.